In:
Current Opinion in Rheumatology, Ovid Technologies (Wolters Kluwer Health), Vol. 34, No. 6 ( 2022-11), p. 351-356
Abstract:
The early heterogenous presentation of systemic sclerosis (SSc), in particular without skin involvement, has been a confounding factor delaying early diagnosis. In fact, early signs of SSc as Raynaud's phenomenon and puffy fingers, are also typical of other connective tissue diseases (CTDs) such as mixed CTD and undifferentiated CTD. In the last decade, a significant effort has been dedicated in defining molecular characteristics that could be used as early SSc biomarkers. In this narrative review, we address the present situation where several clinical scenarios are in search of a correct positioning into the prescleroderma (pre-SSc) phase as well as in the very early phase of SSc. Recent findings Literature data showed that a part of patients classified as sine scleroderma SSc (ssSSc), mixed CTD and undifferentiated CTD may already belong to the very early phase of SSc, thus having a different pattern of progression to SSc. Recently, the very early diagnosis of systemic sclerosis (VEDOSS) criteria has been validated. Summary while the area of pre-SSc still remains fuzzy, the VEDOSS study has shown that a ‘window of opportunity’ does exist also for SSc. In the very next future, this may allow to start the treatment to prevent the disease progression to a more advanced fibrotic stage.
Type of Medium:
Online Resource
ISSN:
1040-8711
,
1531-6963
DOI:
10.1097/BOR.0000000000000903
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2022
detail.hit.zdb_id:
2026973-0
detail.hit.zdb_id:
1045317-9
Permalink